We are live on ! Find out more
WH

Willner & Heller Portfolio holdings

AUM $160M
1-Year Est. Return 45.36%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+45.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
+$1.91M
Cap. Flow
+$492K
Cap. Flow %
0.43%
Top 10 Hldgs %
28.78%
Holding
160
New
8
Increased
80
Reduced
54
Closed
6

Sector Composition

1 Technology 22.07%
2 Healthcare 11.56%
3 Financials 10.84%
4 Consumer Discretionary 5.24%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
151
Johnson & Johnson
JNJ
$609B
$202K 0.18%
1,396
-40
-3% -$6.2K
SPSM icon
152
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$201K 0.18%
4,464
-162
-4% -$7.54K
CLSK icon
153
CleanSpark
CLSK
$3.34B
$134K 0.12%
14,500
VALE icon
154
Vale
VALE
$60.4B
$107K 0.09%
12,100
BDX icon
155
Becton Dickinson
BDX
$43.6B
-1,214
Closed -$293K
DEO icon
156
Diageo
DEO
$46.7B
-1,699
Closed -$238K
GSK icon
157
GSK
GSK
$104B
-13,595
Closed -$556K
KKR icon
158
KKR & Co
KKR
$90.6B
-1,624
Closed -$212K
LHX icon
159
L3Harris
LHX
$52.5B
-1,181
Closed -$281K
THC icon
160
Tenet Healthcare
THC
$16.8B
-1,225
Closed -$204K

Similar funds

Willner & Heller's Q4 2024 Portfolio in Review

As of Q4 2024, Willner & Heller held 160 positions worth $114M, up 1.7% from $112M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Willner & Heller's Q4 2024 filing shows 8 new, 80 increased, 54 reduced and 6 closed positions. Its largest new stake was Lam Research: 11,143 shares worth $805K. The largest sale was NVIDIA, an estimated $629K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Willner & Heller's largest Q4 2024 buy was Lam Research: 11,143 shares worth $805K.
  • Willner & Heller added most to Amgen in Q4 2024, an estimated $391K increase.
  • Willner & Heller's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $629K.
  • Willner & Heller fully exited GSK in Q4 2024, selling an estimated $556K.
  • Willner & Heller's ten largest holdings make up 29% of its $114M portfolio in Q4 2024.
  • Willner & Heller opened 8 new positions and closed 6 in Q4 2024.
  • Willner & Heller's portfolio value rose 1.7% quarter-over-quarter to $114M.

Based on Willner & Heller's 13F filing for Q4 2024, filed 16 Jan 2025.